Functional Interaction of the Ras Effector RASSF5 with the Tyrosine Kinase Lck: Critical Role in Nucleocytoplasmic Transport and Cell Cycle Regulation

Journal of Molecular Biology

Volumn 397, Issue 1, 2010, Pages 89-109

  Kumari, Gita ^a,b   Singhal, P K ^b   Suryaraja, R ^a   Mahalingam, S ^a,b  

^a INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

^b Center for DNA Fingerprinting and Diagnostics   (India)

Author keywords

cell cycle control; Lck; Nucleocytoplasmic transport; phosphorylation; RASSF5

Indexed keywords

BINDING PROTEIN; KARYOPHERIN ALPHA; KARYOPHERIN BETA; LEPTOMYCIN B; PROTEIN KINASE LCK; PROTEIN SH2; PROTEIN SH3; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 5; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL GROWTH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE MUTATION; GENE TRANSLOCATION; GENETIC VARIABILITY; GROWTH REGULATION; HUMAN; HUMAN CELL; HYDROPHOBICITY; IMMUNOFLUORESCENCE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

EID: 77249167127     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.01.005     Document Type: Article

References (42)

1. Khokhlatchev A., Rabizadeh S., Xavier R., Nedwidek M., Chen T., Zhang X.F., et al. Identification of a novel Ras-regulated proapoptotic pathway. Curr. Biol. 12 (2002) 253-265
2. Moshnikova A., Frye J., Shay J.W., Minna J.D., and Khokhlatchev A.V. The growth and tumor suppressor NORE1A is a cytoskeletal protein that suppresses growth by inhibition of the ERK pathway. J. Biol. Chem. 281 (2006) 8143-8152
3. Ortiz-Vega S., Khokhlatchev A., Nedwidek M., Zhang X.F., Dammann R., Pfeifer G.P., and Avruch J. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. Oncogene 21 (2002) 1381-1390
4. Praskova M., Khoklatchev A., Ortiz-Vega S., and Avruch J. Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. Biochem. J. 381 (2004) 453-462
5. Vavvas D., Li X., Avruch J., and Zhang X.F. Identification of Nore1 as a potential Ras effector. J. Biol. Chem. 273 (1998) 5439-5442
6. Hesson L., Dallol A., Minna J.D., Maher E.R., and Latif F. NORE1A, a homologue of RASSF1A tumour suppressor gene, is inactivated in human cancers. Oncogene 22 (2003) 947-954
7. Irimia M., Fraga M.F., Sanchez-Cespedes M., and Esteller M. CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer. Oncogene 23 (2004) 8695-8699
8. Nakamura N., Carney J.A., Jin L., Kajita S., Pallares J., Zhang H., et al. RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors. Lab. Invest. 85 (2005) 1065-1075
9. Kumari G., Singhal P.K., Rao M.R., and Mahalingam S. Nuclear transport of Ras-associated tumor suppressor proteins: different transport receptor binding specificities for arginine-rich nuclear targeting signals. J. Mol. Biol. 367 (2007) 1294-1311
10. Ren R., Mayer B.J., Cicchetti P., and Baltimore D. Identification of a ten-amino acid proline-rich SH3 binding site. Science 259 (1993) 1157-1161
11. Hidaka M., Homma Y., and Takenawa T. Highly conserved eight amino acid sequence in SH2 is important for recognition of phosphotyrosine site. Biochem. Biophys. Res. Commun. 180 (1991) 1490-1497
12. Sakamuro D., Sabbatini P., White E., and Prendergast G.C. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15 (1997) 887-898
13. Kallstrom H., Lindqvist A., Pospisil V., Lundgren A., and Rosenthal C.K. Cdc25A localisation and shuttling: characterisation of sequences mediating nuclear export and import. Exp. Cell Res. 303 (2005) 89-100
14. Yang J., Song H., Walsh S., Bardes E.S., and Kornbluth S. Combinatorial control of cyclin B1 nuclear trafficking through phosphorylation at multiple sites. J. Biol. Chem. 276 (2001) 3604-3609
15. Woods D.B., and Vousden K.H. Regulation of p53 function. Exp. Cell Res. 264 (2001) 56-66
16. Graves P.R., Lovly C.M., Uy G.L., and Piwnica-Worms H. Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding. Oncogene 20 (2001) 1839-1851
17. Fabbro M., and Henderson B.R. Regulation of tumor suppressors by nuclear-cytoplasmic shuttling. Exp. Cell Res. 282 (2003) 59-69
18. Llanos S., Clark P.A., Rowe J., and Peters G. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus. Nat. Cell. Biol. 3 (2001) 445-452
19. Jans D.A., Ackermann M.J., Bischoff J.R., Beach D.H., and Peters R. p34cdc2-mediated phosphorylation at T124 inhibits nuclear import of SV-40 T antigen proteins. J. Cell Biol. 115 (1991) 1203-1212
20. Liku M.E., Nguyen V.Q., Rosales A.W., Irie K., and Li J.J. CDK phosphorylation of a novel NLS-NES module distributed between two subunits of the Mcm2-7 complex prevents chromosomal rereplication. Mol. Biol. Cell 16 (2005) 5026-5039
21. Dingwall C., and Laskey R.A. Nuclear targeting sequences-a consensus?. Trends Biochem. Sci. 16 (1991) 478-481
22. Gorlich D., and Mattaj I.W. Nucleocytoplasmic transport. Science 271 (1996) 1513-1518
23. Doye V., and Hurt E.C. Genetic approaches to nuclear pore structure and function. Trends Genet. 11 (1995) 235-241
24. Kudo N., Matsumori N., Taoka H., Fujiwara D., Schreiner E.P., Wolff B., et al. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc. Natl Acad. Sci. USA 96 (1999) 9112-9117
25. Hutten S., and Kehlenbach R.H. CRM1-mediated nuclear export: to the pore and beyond. Trends Cell Biol. 17 (2007) 193-201
26. Roth J., Dobbelstein M., Freedman D.A., Shenk T., and Levine A.J. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17 (1998) 554-564
27. Xiao Z., Brownawell A.M., Macara I.G., and Lodish H.F. A novel nuclear export signal in Smad1 is essential for its signaling activity. J. Biol. Chem. 278 (2003) 34245-34252
28. Mailand N., Podtelejnikov A.V., Groth A., Mann M., Bartek J., and Lukas J. Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability. EMBO J. 21 (2002) 5911-5920
29. Zhang F., White R.L., and Neufeld K.L. Phosphorylation near nuclear localization signal regulates nuclear import of adenomatous polyposis coli protein. Proc. Natl Acad. Sci. USA 97 (2000) 12577-12582
30. Fabbro M., Rodriguez J.A., Baer R., and Henderson B.R. BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export. J. Biol. Chem. 277 (2002) 21315-21324
31. Glover-Collins K., and Thompson M.E. Nuclear export of BRCA1 occurs during early S phase and is calcium-dependent. Cell. Signalling 20 (2008) 958-968
32. Lu W., Pochampally R., Chen L., Traidej M., Wang Y., and Chen J. Nuclear exclusion of p53 in a subset of tumors requires MDM2 function. Oncogene 19 (2000) 232-240
33. Shaulsky G., Ben-Ze'ev A., and Rotter V. Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene 5 (1990) 1707-1711
34. Moll U.M., LaQuaglia M., Benard J., and Riou G. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc. Natl Acad. Sci. USA 92 (1995) 4407-4411
35. Park S.J., Lee D., Choi C.Y., and Ryu S.Y. Induction of apoptosis by NORE1A in a manner dependent on its nuclear export. Biochem. Biophys. Res. Commun. 368 (2008) 56-61
36. Hirai H., and Varmus H.E. Mutations in src homology regions 2 and 3 of activated chicken c-src that result in preferential transformation of mouse or chicken cells. Proc. Natl Acad. Sci. USA 87 (1990) 8592-8596
37. Wages D.S., Keefer J., Rall T.B., and Weber M.J. Mutations in the SH3 domain of the src oncogene which decrease association of phosphatidylinositol 3′-kinase activity with pp60v-src and alter cellular morphology. J. Virol. 66 (1992) 1866-1874
38. Berger M., Vogt Sionov R., Levine A.J., and Haupt Y. A role for the polyproline domain of p53 in its regulation by Mdm2. J. Biol. Chem. 276 (2001) 3785-3790
39. Berger M., Stahl N., Del Sal G., and Haupt Y. Mutations in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA damage. Mol. Cell. Biol. 25 (2005) 5380-5388
40. Macheiner D., Heller G., Kappel S., Bichler C., Stattner S., Ziegler B., et al. NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma. J. Hepatol. 45 (2006) 81-89
41. Fuerst T.R., Earl P.L., and Moss B. Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. Mol. Cell. Biol. 7 (1987) 2538-2544
42. Mahalingam S., Van Tine B., Santiago M.L., Gao F., Shaw G.M., and Hahn B.H. Functional analysis of the simian immunodeficiency virus Vpx protein: identification of packaging determinants and a novel nuclear targeting domain. J. Virol. 75 (2001) 362-374